Carcinoma, Non-Small-Cell Lung: all 6,641 studies

Page 58 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.

• The Continuation of ErlotinibStatus unknownNCT01130779Phase 2
• Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01130766Phase 3
• Establishment and Characterization of Patient-Derived Non-Small Cell Lung Cancer Xenografts and Cell CulturesStatus unknownNCT01130571
• 131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC)TerminatedNCT01124812Phase 1
• Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib TosylateCompletedNCT01124669
• Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)CompletedNCT01124253Phase 3
• Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung CancerCompletedNCT01118676Phase 1
• A Phase 1 Study in Participants With Advanced CancerCompletedNCT01115790Phase 1
• Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative RadiotherapyCompletedNCT01112631
• Trial Of Cisplatin And KML-001 in Platinum Responsive MalignanciesTerminatedNCT01110226Phase 1
• A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma HistologyCompletedNCT01106781
• Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)CompletedNCT01103089
• A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung CancerStatus unknownNCT01102517Not applicable
• A Retrospective Study of Biomarkers in Non-Small Cell Lung CancerStatus unknownNCT01100840
• Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)CompletedNCT01099124Not applicable
• First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung CancerStatus unknownNCT01097317Phase 2
• Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)Status unknownNCT01091376Phase 2
• Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung CancerTerminatedNCT01090830Phase 1/2
• Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung CancerSuspendedNCT01088620Phase 2
• SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung CancerCompletedNCT01086254Phase 2
• Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01083589Phase 2
• Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)CompletedNCT01081496
• Endobronchial Ultrasound- Transbronchial Needle Aspiration (EBUS-TBNA) Versus Mediastinoscopy for Mediastinal Lymph Node Staging of Non-small Cell Lung Cancer (NSCLC)CompletedNCT01079520Not applicable
• Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming TumorsTerminatedNCT01071434
• An Exploratory Study of RO4929097 in Patients With Recurrent or Refractory Non-Small Cell Lung CancerCompletedNCT01070927Phase 2
• Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)CompletedNCT01069835
• A Study of ARQ 197 in Combination With ErlotinibCompletedNCT01069757Phase 1
• Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung CancerCompletedNCT01069640Phase 1
• Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung CancerCompletedNCT01069575Phase 1
• Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)CompletedNCT01069328Phase 1
• MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous ChemotherapyCompletedNCT01068587Phase 1/2
• Chemotherapy in Treating Patients With Lung CancerCompletedNCT01067794
• A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT01066884Phase 4
• Adjuvant CCRT vs CT in Minimal N2 NSCLCCompletedNCT01066234Phase 2
• Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyStatus unknownNCT01066195Phase 3
• Whole-Body Magnetic Resonance Imaging/Positron Emission Tomography (MRI/PET) in the Staging of Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT01065415
• Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung CancersTerminatedNCT01064050Phase 4
• Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLCTerminatedNCT01063478Phase 1
• Feasibility Study: Comparison of Performance Status With Objective Physical Activity MonitorsTerminatedNCT01063400
• Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced CancerCompletedNCT01061840Phase 1
• A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007CompletedNCT01061788Phase 1
• Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast CancerTerminatedNCT01060514Phase 1
• Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01059552Phase 1
• Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01059188Phase 2
• The Effect Of Aspirin On Survival in Lung CancerWithdrawnNCT01058902Phase 3
• Taxotere-Enoxaparin-(ENOXA)-StudyTerminatedNCT01058759Phase 3
• Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)TerminatedNCT01057212Phase 2
• Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung CancerStatus unknownNCT01054482Phase 2
• A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung AdenocarcinomaCompletedNCT01051934Phase 1
• Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung CancerStatus unknownNCT01051362Phase 2
• Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)WithdrawnNCT01048983Phase 1/2
• Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung CancerCompletedNCT01048645Phase 2
• Molecular Imaging With Erlotinib and BevacizumabCompletedNCT01047059Phase 2
• Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer PatientsTerminatedNCT01046383Phase 3
• Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response BiomarkerStatus unknownNCT01041833Phase 3
• A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung CancerCompletedNCT01039948Phase 1/2
• Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT01038271Not applicable
• First-Line Chemotherapy and Panitumumab in Advanced Non-Small Cell Lung CancerTerminatedNCT01038037Phase 2
• UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung CancerCompletedNCT01037998Phase 2
• A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male VolunteersCompletedNCT01034748Phase 1
• A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01031225Phase 2
• Concomitant Radio-chemotherapy in the ElderlyCompletedNCT01029678Phase 2
• A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01028729Phase 4
• Thermal Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer > 3.5 cm in SizeTerminatedNCT01028612Not applicable
• Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)Status unknownNCT01027676Phase 1/2
• Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung CancerCompletedNCT01026467
• Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLCStatus unknownNCT01024829Not applicable
• Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT01024712Phase 2
• Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01024062Phase 2
• K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic ImplicationsCompletedNCT01023828
• A Trial of Paclitaxel (Genexol®) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) and Cisplatin in Advanced Non Small Cell Lung CancerCompletedNCT01023347Phase 2
• Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With ChemotherapyCompletedNCT01022671Phase 2
• Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung CancerStatus unknownNCT01019798Phase 2
• Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mgCompletedNCT01017679Phase 2
• Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT01017133Phase 1
• Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung MetastasisCompletedNCT01014598Phase 1
• Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01014130Phase 3
• 64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer With Carboplatin, Paclitaxel, and BevacizumabWithdrawnNCT01006226Not applicable
• Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung CancersCompletedNCT01005797Phase 1
• Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung CancerCompletedNCT01004731Phase 1/2
• Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung CancerCompletedNCT01004601Not applicable
• Trial of ZD6474 and Faslodex in Non-Small Cell Lung CancerWithdrawnNCT01004419Phase 1
• Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IVCompletedNCT01003964Phase 2
• Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung CancerStatus unknownNCT01003522Phase 3
• A Study on the Long Term Survivals in an Expand Access Program (EAP) of IressaCompletedNCT01000740Phase 4
• Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With ChemotherapyWithdrawnNCT00998101Phase 2
• Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung CancerStatus unknownNCT00997724Phase 2
• Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or mCompletedNCT00997230
• NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung CancerCompletedNCT00994097Phase 2
• CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)CompletedNCT00991796Phase 2
• Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT00989690Phase 3
• Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance StatusCompletedNCT00986297Phase 1
• Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)SuspendedNCT00986284Phase 2
• Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung CancerWithdrawnNCT00985998Phase 1
• Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung CancerCompletedNCT00985855Phase 2
• Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung CancerTerminatedNCT00983047Phase 2
• EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)Status unknownNCT00982605
• Gene Mutations in Non-Small Cell Lung Cancer CellsStatus unknownNCT00977509
• A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung CancerTerminatedNCT00975767Phase 1
• A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid TumorsCompletedNCT00975182Phase 1

← Carcinoma, Non-Small-Cell Lung overview